Drug Discovery & Development Products & Reviews

Type I-S, 65-85% protein (≥75% of protein is clottable)

1,6-α-D-Glucan 6-glucanohydrolase

Lyophilized powder, ≥6 units/mg solid

Recombinant, expressed in Pichia pastoris, ATPase ≥1000 units/mg protein, lyophilized powder.

Type III-A, ≥85% RNase A basis (SDS-PAGE), 85-140 Kunitz units/mg protein

USP Testing Specific

BioUltra, Molecular Biology, ≥99.5% (RT)

BioUltra, Molecular Biology, ~1 M in H2O

The TA Instruments/Waters Powder Rheology Accessory extends the Discovery Hybrid Rheometer to characterize powder behavior during storage, handling, processing, and use. Quantitative dynamic flow and shear measurements—under ambient or controlled temperature—accelerate development, optimize processes, screen materials, and reveal powder morphology differences to prevent scale‑up issues.

The MBT Pathfinder® and Feeder solution frees laboratory technicians from tedious, time-consuming sample preparation tasks, enabling them to concentrate on high-value activities such as sample interpretation and analysis. Automated MALDI target plate preparation minimizes time-intensive, repetitive, and error-prone manual processes.

Lyophilized, ~9 U/mg

Fast-track your route to a modernized workflow with the only in vitro bioavailability assessment tool on the market

Functions as a coenzyme of a large number of oxidoreductases

The IR Biotyper ® , leveraging FT-IR spectroscopy, enables swift, user-friendly, and cost-effective same-day typing of microbial strains for applications in hospital hygiene, epidemiology, industrial hygiene control, and source tracking.   

Streamlining your MALDI-TOF MS microbiology workflows. The MBT Biotarget 96 is a ready-to-use disposable MALDI-TOF MS target plate for the industry-leading Bruker MALDI Biotyper ® . It streamlines your routine microbiology workflows. The MBT Biotarget 96 enables full traceability with unique barcodes, and it eliminates pre- and post-processing of the target plate making your workflows more productive.

Custom DNA/RNA oligonucleotide synthesis with broad modification choices (PS, 2′-OMe, 2′-F, LNA, GalNAc, dyes/biotin), multiple scales and purifications, and analytical QC. Includes design consultation and documentation to support research, translational studies, and conjugation-ready formats.

Integrated ASO development from sequence design and chemistry selection to preclinical PK/PD, safety, delivery (e.g., GalNAc), and CMC—supporting gapmer and steric-blocker approaches to advance programs efficiently toward IND.

Creative Biolabs has proudly developed the unique Native™ Antibody Discovery Platform to develop native monoclonal antibodies using antigen-specific B lymphocytes cytometry technology.

Creative Biolabs specializes in the discovery of single domain antibodies (sdAbs) with high affinity and specificity.

Comprehensive circRNA services including design, circularization (e.g., ribozyme/intron-mediated), purification, and analytics to deliver stable, translation-competent RNA with improved durability—supported by process development for research and translational programs.

End-to-end viral vector design and construction covering vector/serotype selection, expression-cassette optimization, cloning, packaging, purification, and QC. Supports AAV, lentivirus, adenovirus, HSV, vaccinia, and baculovirus with scalable production and documentation for in vitro/in vivo studies and IND-enabling work.

The Xcyto® 5 combines the power of flow cytometry with the simplicity of imaging. This compact, AI-driven cytometer delivers high-precision analysis for adherent, suspension, and droplet-based samples—without warm-up or clogging. GMP-ready and easy to integrate, it brings effortless accuracy to every lab workflow.

The new standard in benchtop sequencing speed and simplicity

Disruptive technology for the characterization of small molecules and fragments. With enhanced sensitivity, expanded thermal options, and advanced microfluidics, the Carterra Ultra™ platform is our most sensitive instrument for interrogating multiple proteins and off-target binding in parallel.

Disruptive Technology for Screening and Characterization. Enhanced sensitivity and fast data collection rate build upon unmatched capabilities in throughput and enable assays such as TPDs/PROTAC®s, kinase, cytokines, DELs, and protein:protein inhibitors.